Skip to Content

654 (Glyburide and Metformin Hydrochloride 2.5 mg / 500 mg)

Pill with imprint 654 is Yellow, Capsule-shape and has been identified as Glyburide and Metformin Hydrochloride 2.5 mg / 500 mg. It is supplied by Cadila Healthcare Limited.

Glyburide/metformin is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glyburide/metformin 2.5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 654

Glyburide and metformin hydrochloride 2.5 mg / 500 mg 654

Glyburide and Metformin Hydrochloride

Imprint:
654
Strength:
2.5 mg / 500 mg
Color:
Yellow
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antidiabetic combinations
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Cadila Healthcare Limited
National Drug Code (NDC):
65841-0825

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide